Thus, we designed the current study to evaluate the preoperative serum levels of CA125 in patients with endometrial cancer in relation to clinicopathological parameters, and whether these serum levels could provide additional information in determining the extent of surgical management. The gene discussed is MUC16; the disease is endometrial cancer.